Class Dismissed: US FDA’s ‘Dean’ Bob Temple Retiring After 52 Years

Robert Temple, the US FDA’s most experienced drug regulator, is currently serving an emeritus role at the agency. The immediate impact of his departure will be mostly symbolic, but still unsettling.

The departure of Robert Temple, deputy CDER director for clincal science, marks the end of an era for the FDA. (File)

More from US FDA

More from R&D